Treatment with linsitinib, an IGF-1 receptor inhibitor, attenuates disease development and progression in an experimental model of Graves’ Orbitopathy von Gulbins, Anne Renate Liselotte, Horstmann, Mareike, Oeverhaus, Michael, Banga, J. Paul, Floegel, Ulrich, Daser, Anke, Krause, Gerd, Spencer, Andrew, Zeidan, Ryan, Hammer, Gary Douglas, Bechrakis, Nikolaos E., Philipp, Svenja, Eckstein, Anja, Goertz, Gina-Eva

Volltext